NCT06613165View on ClinicalTrials.gov

Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

September 20, 2026

Study Completion Date

September 20, 2028

Conditions

Immune-related Adverse EventNeoadjuvant TherapydMMR Colorectal Cancer

Trial Locations (1)

Unknown

RECRUITING

Xijing hospital, Xi'an

All Listed Sponsors

lead

Xijing Hospital

OTHER